NUCLEIC ACID VACCINES
Application
US20260091104A1
Kind: A1
Apr 02, 2026
Assignee
ModernaTX, INC.
Inventors
Giuseppe CIARAMELLA, Axel BOUCHON, Eric YI-CHUN HUANG
Abstract
The invention relates to compositions and methods for the preparation, manufacture, and therapeutic use of ribonucleic acid vaccines comprising polynucleotide molecules encoding one or more antigens.
CPC Classifications
A61K 39/145
A61K 9/0019
A61K 9/1271
A61K 9/5123
A61K 9/5146
A61K 31/7105
A61K 39/12
A61K 39/155
A61K 39/39
A61K 48/00
C12N 7/00
A61K 2039/53
A61K 2039/545
A61K 2039/55555
C12N 2760/16122
C12N 2760/16134
C12N 2760/16234
Filing Date
2025-04-24
Application No.
19188713